Our coverage of tirzepatide appetite suppression timelines addresses many of the same gastrointestinal management strategies applicable to retatrutide protocols
May 1, 2026: Judge in Ozempic MDL Issues Two Discovery Orders as Number of NAION Claims Approaches 90 There are 86 claims in the multidistrict litigation about whether Ozempic and other GLP-1s caused some patients to develop NAION
Diet plays a direct role in managing all of these certain food choices reduce GI symptoms, others reliably make them worse
In our first-ever thematic equity basket, lets take a look at the GLP-1 market, its players, and how to build an optimal GLP-1 portfolio
Exendin-4 ameliorates tau hyperphosphorylation and cognitive impairment in type 2 diabetes through acting on Wnt/-catenin/NeuroD1 pathway
Haykal D, Hersant B, Cartier H, Meningaud JP